2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¾ö¸¶´Â ´Ù½Ã ÀÏÇÒ Áغñ Áß (2022-02-17)
ÇÏÀÌÆ®Áø·Î, »óÅ­ÇÑ ¡®ºñŸ500¿¡À̽½¡¯ ÇÑÁ¤ Ãâ½Ã (2022-09-16)
ÅÂdz ¼Ö¸¯ ¹× È£¿ì ÇÇÇØ Àç³­¾ÈÀü Ưº°±³ºÎ¼¼ Áö¿ø (2018-09-10)
Yokogawa Selected as MAC for Construction of Europe¡¯s Large... (2022-09-26)
´ã¾ç°ïÃæ¹Ú¹°°ü, º½¸ÂÀÌ Æ¯º°Àü½Ã ÇØ¼³ ÁøÇà (2019-04-29)
11¿ù °¡Àå ¸¹ÀÌ °Å·¡µÈ ¾ÏȣȭÆó´Â ºñÆ®ÄÚÀÎ (2019-11-26)
¸ÞŸ¹ö½º °ø°£¿¡ ¡®¸®ºê »÷µå¹Ú½º ¾Æ·¹³ª¡¯ ¿ÀÇ (2021-08-20)
¸¸³ª¸ô, È£ÁÖ ¾ÖÇøÁ°í 1+1 ÇÁ·Î¸ð¼Ç (2019-12-16)
´ëÇа¡ ¼øÈ¸ ÆË¾÷½ºÅä¾î ¡®¸Æ½ººÀ ¿¡³ÊÁö Ä«Æä¡¯ (2018-04-22)
LGÈ­ÇÐ, Â÷º°È­µÈ ¼ÒÀç·Î Áß±¹ ½ÃÀå °ø·«ÇÑ´Ù (2018-04-22)
Äڷγª19 °æÇè ÅëÇØ Áö¼Ó°¡´ÉÇÑ Áö¿ª Ȱ¼ºÈ­ (2021-02-10)
Á÷ÀåÀÎ Á¡½É°ª Æò±Õ 6,110¿ø.. Àü³â ´ëºñ 2% ÁÙ¾î (2019-06-08)
¿¡¸£¸Þ½º ÇÚµå¹é, ¸íǰ ÅõÀÚ ÁöÇ¥ 1À§ (2021-03-02)
¡®¹é³âµ¿¾È ¸¶ÀÌÅ©·Î¹ßÈ¿ °Ç°­Áó¡¯ ÇÒÀÎ Çà»ç (2020-01-25)
Çѱ¹ ½Ã´Ï¾î¸ðµ¨ ÇÒ¸®¿ìµå ·±¿þÀÌ¿¡ ¼±´Ù (2019-07-08)
°³ÀÎÇϼö󸮽ü³ Á¡°Ë°á°ú, À§¹ÝÀ² 9% (2012-11-19)
EU ÃÖ´ë Àα¸ ±¹°¡¿¡ Àü±¹¹Î °æº¸ ¹ß¼Û (2021-09-29)
»ê¾÷Çõ½Å ÁÖµµÇÏ´Â µÎ³úÀü¹®±â¾÷ º»°Ý À°¼º (2014-02-04)
½¦º¸·¹ ¸»¸®ºÎ, Ä«¸¶·Î¿Í ¾ËÆä¿Â, Ú¸ JDÆÄ¿ö ³»±¸ ǰÁúÁ¶»ç 1À§ (2015-04-02)
½ÅÇÑÄ«µå¡¤Â÷ÅõÂ÷, ¡®Ä§¼öÂ÷ º¸»óÇÁ·Î±×·¥¡¯ ½Ç½Ã (2018-07-11)
ÇÁ·£Â÷ÀÌÁî ¾÷°è´Â Áö±Ý ¡®¿©Ç³´ç´ç¡¯ (2014-04-25)
Àü³²µµ, 70³â´ë »õ¸¶À»»ç¾÷ µµ·Î ¹«»ó ºÐÇÒÃø·® ½Ç½Ã (2013-04-08)
¾ÈÀüÇàÁ¤ºÎ, ÅðÁ÷ °ø¹«¿ø ±³À° ½Ç½Ã (2013-04-08)
¾ó±¼ ÀÎ½Ä Ã⡤Åð±Ù °ü¸® ¼­ºñ½º ¡®ÀΟÀÓºñÁî ¹«¼± LTEÆÑ¡¯ (2018-02-10)
Çö´ë¿¤¸®º£ÀÌÅÍ, Áõ°­Çö½Ç µðÀÚÀÎ ¼±Åà ½Ã½ºÅÛ °³¹ß (2019-03-19)
       [ÀÌÀü][1]....[3096][3097][3098][3099][3100][3101][3102][3103][3104]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..